Table 3.

Quantitive analysis of RT-PCR and immunohistochemistry results ($\overline{x}\pm s$).

Group	n	ARC	ILRC	IRC	ICD	NRC	CRC	AC
NC	5	0.73 ± 0.20	0.57 ± 0.13	−4.14 ± 0.14	2.51 ± 0.26	−5.02 ± 0.19	−5.18 ± 0.11	0.21 ± 0.05
HF	5	1.61 ± 0.19*	1.57 ± 0.22*	−5.20 ± 0.09*	2.37 ± 0.08	−3.99 ± 0.33*	−4.19 ± 0.12*	0.72 ± 0.10*
HF+S	5	1.95 ± 0.11∗#	1.93 ± 0.17∗#	−5.42 ± 0.07∗#	1.45 ± 0.14∗#	−3.40 ± 0.14∗#	−3.84 ± 0.11∗#	0.98 ± 0.04∗#
HF+T+S	5	1.72 ± 0.14∗★	1.67 ± 0.11∗★	−5.33±0.05∗▲★	1.78 ± 0.12∗#∇	−3.62 ± 0.12∗▲★	4.02 ± 0.07∗▲★	0.84 ± 0.06∗▲∇

ARC: AT1R mRNA relative content; ILRC: IL-1β mRNA relative content; IRC: insulin raltive concentration; ICD: insulin positive cell density; NRC: NF-κB relative concentration; CRC: caspase-3 relative concentration; AC: apoptosis cells of unit islet area.

NC: normal control group; HF: high-fat diet group; HF+S: high-fat diet plus STZ intraperitoneal injection group; HF+T+S: high-fat diet plus telmisartan intervention and STZ intraperitoneal injection group.

^● P < 0.05; *P < 0.01 as compared with NC group; ^▲ P < 0.05, ^#<0.01 as compared with HF group; ^★<0.05, ^∇<0.01 as compared with HF+S group.